| Chairman |
|
Tan Zheng |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman: Tan Zheng
Non-executive Director: Li Siru, Li Mingqiu, Deng Feng
Independent Non-executive Director: Lam Yiu Por, Duan Tao, Li Yuezhong.
|
| Principle Business |
|
The Group is principally engaged in the provision of cognitive impairment digital therapeutics integral software solutions in the PRC. |
| Related Indexes | | Hang Seng Composite Index | Hang Seng Healthcare Index | | Hang Seng Composite SmallCap Index | Hang Seng Healthcare Industry Index |
|
| Major Shareholders |
| Tan Zheng | 275,468,000 | 21.75% | 2025/01/08 | | Wang Xiaoyi & ASSO | 183,955,000 | 14.53% | 2025/01/08 | | Northern Light Partners IV L.P. | 126,854,000 | 10.02% | 2025/01/08 | | Li Mingqiu | 123,527,000 | 9.76% | 2025/01/08 | | Healthblooming Limited | 99,104,000 | 7.83% | 2025/01/08 | | Trident Trust Company (HK) Limited | 85,166,000 | 6.73% | 2025/01/08 | | Suzhou Ceyuan Fuhai Enterprise Management Partnership | 70,525,000 | 5.57% | 2025/01/08 | | Lyu Yajun | 70,143,000 | 5.54% | 2025/01/08 |
|
|
|
|